Articles Posted in NDMA

Zantac Complaint, Part 3: Four Ways Ranitidine Tranforms into NDMA
Clay Hodges

In Part 2 of this series we looked at the development of ranitidine (brand name Zantac), its rise as a hugely profitable heartburn drug, and the discovery that the carcinogen NDMA was found in rantidine, eventually leading to its recall and removal from the market. In this Part 3 I discuss how ranitidine can evolve…

Continue reading ›
Zantac Master Complaint, Part 2: Invention of Ranitidine, Discovery of NDMA
Clay Hodges

In Part 1 I discussed the concept of the Master Complaint in product liability multi-district litigation, and we also set the table with the plaintiffs and the many defendant-companies involved in the Zantac litigation. Now let’s keep grinding through the Zantac Master Complaint. The story of Zantac, the presence of the carcinogen NDMA, and the…

Continue reading ›
Zantac Litigation Master Complaint Key Points, Part 1: The Parties Involved
Clay Hodges

If you truly want to learn about a particular litigation involving a defective product (such as Zantac), the best place to start is the Master Complaint. This is the lengthy comprehensive document filed by the plaintiffs in a multi-district litigation involving a defective product. This does not mean the case is a class action. Most…

Continue reading ›
Zantac: An Update and an Overview of Its Link to Cancer
Clay Hodges

Earlier this year I wrote a blog post that discussed the recent revelation that Zantac might cause cancer. Scientists found a link between N-Nitrosodimethylamine (NDMA), a likely cancer-causing substance, and ranitidine, the key ingredient in Zantac. A few things have changed since that blog post, such as the U.S. Food and Drug Administration (FDA) asking…

Continue reading ›
Zantac: Overview of Recall and Lawsuits Due to Cancer-Causing NDMA
Clay Hodges

Many of us suffer from heartburn, and one of the most popular ways to treat it is by taking Zantac. Until recently, Zantac was considered a very safe medication and was available without a prescription. Given how well it worked, along with its affordable price and the perception of safety, hundreds of thousands of people,…

Continue reading ›
Carcinogens Found in Valsartan Drugs Lead to Massive Recall
Clay Hodges

On November 27, 2018, Teva Pharmaceuticals announced a huge recall of all products containing the medication valsartan. The prescription medications containing valsartan may contain chemicals that are considered possible carcinogens. So What is Valsartan? Valsartan is a drug used to treat hypertension, high blood pressure, congestive heart failure, and other conditions. It also improves health…

Continue reading ›

Client Reviews

Clay Hodges is a good lawyer and a good man. He always takes the time to help you understand exactly what is happening and what's to come. He shows genuine care for his clients. I would highly recommend him.

— Chris Wensil

The attorneys did an excellent job of articulating the legal language of the case. It was a learning process for me that required patience and trust. I can’t thank Spiggle Law & Clay Hodges enough. I’m grateful for other firms saying “no” to me in the process because many of them did not have the...

R.E.

Hi Clay, Just wanted to share that I stumbled across your podcast and it has been the most informative that I have come across. I’ve learnt more and enjoyed every minute and entertained people on the train to no end with the shock on my face. Keep up the good work and have a good one!

J.V.

Contact Us Now

Mallet

Free Consultation (919) 830-5602

Free Books